First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation
Authors:
- 12 May 2011
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 117 (19) , 5257-5260
Abstract
Donor cell leukemia after allogeneic hematopoietic stem cell transplantation might provide a unique human model for our understanding of leukemogenesis in vivo. We hypothesized that the “2-genetic-hits model” may contribute to the “leukemization” of donor cells and first evaluated these genetic mutations that are implicated in the development of acute myeloid leukemia in a donor cell leukemia patient and donor. The patient and his donor-sister both harbored a germline mutation in CEBPA (584_589dup). Susceptible donor hematopoietic cells evolved to overt acute myeloid leukemia by developing 2 somatic CEBPA mutations (247dupC and 914_916dup) in the patient9s microenvironment. These were identical to the acquired mutations identified in leukemic cells that originated from the patient during de novo acute myeloid leukemia. Our results provide the first report of multiple mutations of CEBPA contributing to the transformation of donor cells to the leukemic phenotype and provide clues to support the multiple-genetic-hits mechanism of donor cell leukemia.Keywords
This publication has 16 references indexed in Scilit:
- Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2008
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid LeukemiaNew England Journal of Medicine, 2008
- Deregulated Ras signaling in developmental disorders: new tricks for an old dogCurrent Opinion in Genetics & Development, 2007
- Nucleophosmin and cancerNature Reviews Cancer, 2006
- Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- C/EBPα mutations in acute myeloid leukaemiasNature Reviews Cancer, 2004
- The role of FLT3 in haematopoietic malignanciesNature Reviews Cancer, 2003
- The role of MLL in hematopoiesis and leukemiaCurrent Opinion in Hematology, 2002
- Two genetic hits (more or less) to cancerNature Reviews Cancer, 2001
- LEUKÆMIC TRANSFORMATION OF ENGRAFTED HUMAN MARROW CELLS IN VIVOThe Lancet, 1971